Digestives & Intestinal Remedies - Sudan

  • Sudan
  • In Sudan, the revenue in the Digestives & Intestinal Remedies market market reached US$8.96m in 2024.
  • It is projected to experience an annual growth rate of 1.49% (CAGR 2024-2029).
  • When compared globally, in China leads the market with a revenue of US$4,408.00m in 2024.
  • In terms of per capita income, each person in Sudan generated US$0.18 in revenue in 2024.
  • Sudan's Digestives & Intestinal Remedies market is witnessing a surge in demand due to the increasing prevalence of gastrointestinal disorders among its population.

Key regions: Brazil, India, United Kingdom, Germany, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in Sudan is experiencing significant growth and development.

Customer preferences:
Customers in Sudan are increasingly seeking digestive and intestinal remedies to address common health issues such as indigestion, bloating, and constipation. This trend can be attributed to the changing dietary habits and lifestyles in the country. With the increasing consumption of processed and fast food, as well as a sedentary lifestyle, digestive issues have become more prevalent among the population. As a result, there is a growing demand for products that can provide relief and promote digestive health.

Trends in the market:
One of the key trends in the Digestives & Intestinal Remedies market in Sudan is the rising popularity of natural and herbal remedies. Consumers are becoming more conscious about the ingredients used in the products they consume and are opting for natural alternatives. This trend is in line with the global shift towards natural and organic products. As a result, we are seeing an increasing number of digestive and intestinal remedies in the market that are made from natural ingredients and claim to have fewer side effects.Another trend in the market is the growing availability of over-the-counter (OTC) products. Previously, consumers in Sudan had limited access to digestive and intestinal remedies and had to rely on prescription medications. However, with the expansion of the retail sector and the increasing number of pharmacies, OTC products have become more accessible to the general public. This has led to a significant increase in the sales of digestive and intestinal remedies in the country.

Local special circumstances:
Sudan is a country with a diverse population and a rich cultural heritage. Traditional medicine and herbal remedies have always been an integral part of the Sudanese culture. This has influenced the preferences of consumers in the Digestives & Intestinal Remedies market. Many consumers in Sudan still rely on traditional remedies for digestive issues and prefer products that are based on traditional recipes. This presents an opportunity for companies to develop products that cater to the local preferences and incorporate traditional ingredients.

Underlying macroeconomic factors:
The growth of the Digestives & Intestinal Remedies market in Sudan can be attributed to several underlying macroeconomic factors. Firstly, the country has been experiencing economic growth in recent years, which has led to an increase in disposable income among the population. This has allowed consumers to spend more on healthcare and wellness products, including digestive and intestinal remedies.Secondly, there has been a significant improvement in the healthcare infrastructure in Sudan. The government has been investing in healthcare facilities and promoting awareness about the importance of preventive healthcare. This has led to an increased focus on digestive health and an overall increase in the demand for related products.In conclusion, the Digestives & Intestinal Remedies market in Sudan is witnessing growth and development due to changing customer preferences, including a preference for natural remedies, the increasing availability of OTC products, and the incorporation of traditional ingredients. These trends are supported by underlying macroeconomic factors such as economic growth and improved healthcare infrastructure.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)